Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.56 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.51 |
| ▸ | APP | P05067 | 2/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | IKBKB | O14920 | 2/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | CHUK | O15111 | 1/20 | 0.41 |
| ▸ | IKBKG | Q9Y6K9 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | ERN1 | O75460 | 1/20 | 0.40 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.40 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22508438 | 0.89 | KDM1A (0.49) | KDM1ACYP11B1CYP11B2APPCYP19A1 | |
| SCHEMBL19794423 | 0.85 | KDM1A (0.53) | KDM1ACYP11B1CYP11B2APPCYP19A1 | |
| SCHEMBL18490715 | 0.81 | CYP19A1 (0.51) | KDM1ACYP11B1CYP11B2APPCYP19A1 | |
| SCHEMBL25061124 | 0.81 | KDM1A (0.45) | KDM1ACYP11B1CYP11B2APPCYP19A1 | |
| SCHEMBL5768436 | 0.79 | APP (0.72) | APPHSD17B1HSD17B2CA1CA2 | |
| SCHEMBL13201335 | 0.79 | KDM1A (0.64) | KDM1ACYP11B1CYP11B2APPCYP19A1 | |
| SCHEMBL4821816 | 0.79 | KDM1A (0.57) | KDM1ACYP11B1CYP11B2APPCYP19A1 | |
| SCHEMBL4014804 | 0.79 | KDM1A (0.57) | KDM1ACYP11B1CYP11B2APPCYP19A1 | |
| SCHEMBL28911362 | 0.79 | KDM1A (0.57) | KDM1ACYP11B1CYP11B2APPCYP19A1 | |
| SCHEMBL13017787 | 0.79 | KDM1A (0.57) | KDM1ACYP11B1CYP11B2APPCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1239526-B1 | Metal coordination compound, luminescence device and display apparatus | CANON KK (JP) | 2008-12-17 | — | — | EP | disclosed |
| US-7354662-B2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2008-04-08 | — | — | US | disclosed |
| US-7354662-B2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2008-04-08 | — | — | US | disclosed |
| US-7354662-B2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2008-04-08 | — | — | US | disclosed |
| US-20060022588-A1 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2006-02-02 | — | — | US | disclosed |
| US-6974639-B2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2005-12-13 | — | — | US | disclosed |
| US-20030068536-A1 | Such as bis(4-biphenyl-4-yl)pyridine-C3-N3)(acetylacetonato-) iridium (III); brightness; phosphorescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2003-04-10 | — | — | US | disclosed |
| EP-1239526-A2 | Metal coordination compound, luminescene device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2002-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060022588-A1 | Metal coordination compound, luminescence device and display apparatus | MCOLN2, MCOLN1, CYC1 | KDM1A 2599/4885CYP11B1 1404/4885CYP11B2 1284/4885 |
| US-20030068536-A1 | Such as bis(4-biphenyl-4-yl)pyridine-C3-N3)(acetylacetonato-) iridium (III); brightness; phosphorescence; graphic arts | CYC1, CYCS, CCNA1 | KDM1A 2665/4885CYP11B1 1273/4885CYP11B2 1530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.